Truist Financial
HALO icon

Truist Financial’s Halozyme HALO Stock Holding History

Truist Financial’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
20,197
+725
+4% +$49.4K ﹤0.01% 1511
2026
Q1 		$1.26M Buy
19,472
+246
+1% +$17.3K ﹤0.01% 1586
2025
Q4 		$1.29M Sell
19,226
-30,957
-62% -$2.08M ﹤0.01% 1530
2025
Q3 		$3.68M Sell
50,183
-5,814
-10% -$386K 0.01% 1033
2025
Q2 		$2.91M Sell
55,997
-4,811
-8% -$274K ﹤0.01% 1102
2025
Q1 		$3.88M Sell
60,808
-12,350
-17% -$717K 0.01% 936
2024
Q4 		$3.5M Sell
73,158
-2,076
-3% -$106K 0.01% 983
2024
Q3 		$4.31M Sell
75,234
-9,231
-11% -$529K 0.01% 887
2024
Q2 		$4.42M Sell
84,465
-16,876
-17% -$740K 0.01% 906
2024
Q1 		$4.12M Sell
101,341
-1,281
-1% -$48K 0.01% 959
2023
Q4 		$3.79M Buy
102,622
+563
+0.6% +$21.2K 0.01% 967
2023
Q3 		$3.9M Buy
102,059
+1,553
+2% +$63.6K 0.01% 934
2023
Q2 		$3.63M Buy
100,506
+3,264
+3% +$111K 0.01% 975
2023
Q1 		$3.71M Buy
97,242
+11,296
+13% +$530K 0.01% 954
2022
Q4 		$4.89M Buy
85,946
+12,035
+16% +$616K 0.01% 822
2022
Q3 		$2.92M Buy
73,911
+43,581
+144% +$1.93M 0.01% 997
2022
Q2 		$1.33M Sell
30,330
-1,291
-4% -$55.8K ﹤0.01% 1414
2022
Q1 		$1.26M Buy
31,621
+105
+0.3% +$3.74K ﹤0.01% 1513
2021
Q4 		$1.27M Sell
31,516
-733
-2% -$27.4K ﹤0.01% 1515
2021
Q3 		$1.31M Buy
32,249
+622
+2% +$26K ﹤0.01% 1462
2021
Q2 		$1.44M Buy
31,627
+2,729
+9% +$121K ﹤0.01% 1447
2021
Q1 		$1.21M Buy
28,898
+5,490
+23% +$251K ﹤0.01% 1474
2020
Q4 		$1M Sell
23,408
-3,692
-14% -$133K ﹤0.01% 1479
2020
Q3 		$711K Buy
27,100
+3,150
+13% +$87.7K ﹤0.01% 1535
2020
Q2 		$642K Buy
23,950
+5,245
+28% +$118K ﹤0.01% 1493
2020
Q1 		$336K Sell
18,705
-2,007
-10% -$38.1K ﹤0.01% 1791
2019
Q4 		$367K Buy
+20,712
New +$359K ﹤0.01% 2045

Other funds holding HALO

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Truist Financial's HALO Position: Q2 2026 in Review

Truist Financial increased its Halozyme (HALO) stake by 3.7% in Q2 2026, buying an estimated $49.4K and bringing the position to 20,197 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Truist Financial first reported a position in HALO in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.89M in Q4 2022. 316 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Truist Financial held 20,197 shares of Halozyme worth $1.58M as of Q2 2026.
  • Truist Financial bought 725 Halozyme shares in Q2 2026, an estimated $49.4K.
  • Halozyme made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1511 holding.
  • Truist Financial first reported a position in Halozyme in Q4 2019 and has held it in 27 quarters since.
  • Truist Financial's Halozyme position peaked at $4.89M in Q4 2022.
  • 316 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.